PCR-based MRD testing for acute lymphoblastic leukaemia in India

Bibliographic Details
Published in:	Pediatric Hematology Oncology Journal
Main Authors:	Rubina Islam, Debparna Saha, Debdutta Ganguli, Arindam Basu, Neeraj Arora, Deepak Mishra, Vaskar Saha, Shekhar Krishnan
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S246812451730205X

Similar Items

Development of a targeted sequencing panel for Indian patients with acute Lymphoblastic Leukaemia
by: Debdutta Ganguli, et al.
Published: (2017-01-01)

Evolving strategies in the management of relapsed acute lymphoblastic leukaemia – TMCKidsALLR1
by: Prakriti Roy, et al.
Published: (2017-01-01)

Distinct heterogeneity in Indian patients with high hyperdiploid precursor B cell all identified by high density array analysis
by: Mayur Parihar, et al.
Published: (2017-01-01)

Aberrant TP53 pathways regulate leukaemic cell survival in acute lymphoblastic leukaemia
by: Pritha Paul, et al.
Published: (2017-01-01)

Effective standardisation and personalisation optimise the management of acute lymphoblastic leukaemia maintenance treatment and improve outcomes
by: Manash Pratim Gogoi, et al.
Published: (2024-01-01)

Establishment of a biorepository of paediatric cancers: The Tata Medical Center experience
by: Arindam Basu, et al.
Published: (2017-01-01)

A shorter induction corticosteroid reduces acute lymphoblastic leukaemia induction deaths in the icicle-all-14 randomised trial
by: Parag Das, et al.
Published: (2024-01-01)

Hematrack: High sensitivity measurable residual disease (MRD) monitoring in acute lymphoblastic leukemia with NGS
by: Vineeth Surendranath, et al.
Published: (2024-01-01)

Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata
by: Debjani Ghosh, et al.
Published: (2022-01-01)

Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial
by: Jasmeet Sidhu, et al.
Published: (2017-01-01)

Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaResearch in context
by: Manash Pratim Gogoi, et al.
Published: (2025-06-01)

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
by: Tushar Mungle, et al.
Published: (2023-02-01)

Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance: Benefits and potential risks
by: Duhita Sengupta, et al.
Published: (2024-01-01)

Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial.
by: Ashish Narayan Masurekar, et al.
Published: (2014-01-01)

ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
by: Inge van Outersterp, et al.
Published: (2023-10-01)

Using the EURONET-PHL-C1 strategy of limiting anthracycline and radiotherapy exposure using PET-CT as a response-assessment tool in children with classical Hodgkin lymphoma: Experience form Tata Medical Centre, Kolkata
by: Sheetal Kulkarni Modi, et al.
Published: (2017-01-01)

Feasibility of a mitoxantrone-based induction protocol in childhood acute myeloid leukemia: Follow up experience of 2 year cohort from Tata Medical Center, Kolkata
by: Dipshikha Maiti, et al.
Published: (2016-01-01)

Cytogenetics in Acute Lymphoblastic Leukaemia Patients: A Retrospective Study from a Teaching Hospital in Karnataka, India
by: Girish Kamat, et al.
Published: (2022-10-01)

Analysis of <it>ZAP70</it> expression in adult acute lymphoblastic leukaemia by real time quantitative PCR
by: Chakupurakal Geothy, et al.
Published: (2012-05-01)

Evaluation of Relationship between Minimal Residual Disease (MRD) and Relapse in Childhood Acute Lymphoblastic Leukemia (ALL) Using Quantitative Fluorescent PCR
Published: (2005-09-01)

Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
by: Irene Della Starza, et al.
Published: (2021-03-01)

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia
by: Owen J. McGinn, et al.
Published: (2017-06-01)

Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario
by: Anne Tierens, et al.
Published: (2021-03-01)

B-lymphoblastic leukaemia presenting as intrahepatic cholestasis
by: Daniyal Raza, et al.
Published: (2023-10-01)

Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia
by: Jasmeet Sidhu, et al.
Published: (2022-01-01)

Flowcytometric and DNA Analysis Minimal Residual Disease (MRD) in Childhood B-Lineage lymphoblastic leukemia
by: Vossough P, et al.
Published: (2005-07-01)

Flowcytometric and DNA Analysis Minimal Residual Disease (MRD) in Childhood B-Lineage lymphoblastic leukemia
by: P Vossough, et al.
Published: (2005-06-01)

Comparative Analysis of Treatment Standards for Acute Lymphoblastic Leukaemia
by: Rakhmonova G.A., et al.
Published: (2025-09-01)

Prophylactic probiotics for diarrhoea in children with acute lymphoblastic leukaemia
by: Zamil Ahmed, et al.
Published: (2024-01-01)

Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance treatment
by: Akshay Kamle, et al.
Published: (2022-01-01)

What Role for Angiogenesis in Childhood Acute Lymphoblastic Leukaemia?
by: P. Schneider, et al.
Published: (2011-01-01)

KMT2A-rearranged acute lymphoblastic leukaemia
by: Rishi S. Kotecha, et al.
Published: (2024-12-01)

Immunophenotyping of T-cell acute lymphoblastic leukaemia: Practical hurdles
by: Priya Pai, et al.
Published: (2023-10-01)

T-cell lymphoblastic leukaemia: The Johannesburg state-sector experience
by: Jenifer Vaughan, et al.
Published: (2022-06-01)

Associação entre marcadores inflamatórios e fatores de risco cardiovascular em mulheres de Kolkata, W.B, Índia Asociación entre marcadores inflamatorios y factores de riesgo cardiovascular en mujeres de Kolkata, W.B, India Association between inflammatory markers and cardiovascular risk factors in women from Kolkata, W.B, India
by: Debdutta Ganguli, et al.
Published: (2011-01-01)

Clinical presentation & outcome of paediatric philadelphia-positive acute lymphoblastic leukaemia (Ph +ve ALL) using aggressive chemotherapy with imatinib in India
by: Kalasekhar Vijayasekharan, et al.
Published: (2016-01-01)

Primary renal leukaemia in a young adult male as an extramedullary presentation of T cell acute lymphoblastic leukaemia
by: Punit Jain, et al.
Published: (2024-02-01)

Spectrum of respiratory viral infections in children with cancers: Experience from a tertiary cancer centre in Eastern India
by: Arpita Bhattacharyya, et al.
Published: (2016-01-01)

Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations
by: Klaus Rehe, et al.
Published: (2012-12-01)

Growth patterns in children and adolescents treated for acute lymphoblastic leukaemia
by: Krisha Savla, et al.
Published: (2025-12-01)